top of page
Search

China’s Aishelun Medical Advances €19 Million Manufacturing Investment in Morocco

  • Writer: Sinolink
    Sinolink
  • Aug 16
  • 3 min read


Chinese medical textile and healthcare products manufacturer Jiangsu Aishelun Medical Technology Group is moving forward with its industrial investment in Morocco, reinforcing the country’s growing position as a manufacturing base for Chinese companies targeting European, Middle Eastern and African markets.

In July 2026, Aishelun’s board approved an investment agreement with the Moroccan government covering MAD 203.7 million (approximately €19 million). The decision was unanimously approved by the company’s board, according to its filing with the Beijing Stock Exchange, where Aishelun is listed under ticker 920050.

The agreement remains subject to approval by the relevant Moroccan authorities.

A New Manufacturing Base in Tangier Tech

The investment concerns the first phase of a manufacturing project developed by InnovMed Tech Group, Aishelun’s wholly owned Moroccan subsidiary, incorporated on November 26, 2024 in Mohammed VI Tangier Tech City.

The project occupies nearly 6 hectares of land, with approximately 31,300 square meters of built-up area planned during the first phase, including production workshops, warehouses and offices.

Construction is expected to take approximately one year. Aishelun had previously increased the project’s overall investment ceiling to €20 million, while construction officially started on May 24, 2026.

Once operational, the facility is expected to manufacture annually:

  • 150 million disposable underpads

  • 72 million adult diapers

  • 10 million urinary drainage bags

The plant is expected to reach full production capacity within two to three years after commissioning, with annual output estimated at around RMB 200 million (€24 million).

Local Integration and Employment Commitments

Beyond the financial investment, the agreement includes several commitments designed to increase the project’s contribution to Morocco’s local industrial ecosystem.

InnovMed is expected to increase its paid-in capital to more than MAD 20 million within 12 months and create sustainable employment opportunities.

Importantly, 35% of the project’s payroll budget is expected to be allocated to female employees, while the company has committed to achieving a minimum local integration rate of 20%.

Aishelun will also prioritize Moroccan suppliers and service providers whenever possible.

The overall investment program must be completed within five years unless an amendment is agreed, while progress reports must be submitted every six months to the Regional Investment Center (CRI).

Moroccan Government Support and Industrial Zone Incentives

Under the investment agreement, Moroccan authorities are expected to provide investment subsidies in several installments while ensuring access to the customs and tax incentives associated with Morocco’s Industrial Acceleration Zones (Zones d’Accélération Industrielle – ZAI).

These incentives are accompanied by strict implementation requirements. Failure to respect investment deadlines, significant changes to the nature of the project or misuse of the allocated industrial land could lead to termination of the agreement and repayment of subsidies already received.

This structure reflects Morocco’s increasingly performance-based approach to industrial incentives: public support is linked to concrete commitments involving investment, employment, local sourcing and project execution.

Morocco as a Regional Export Platform

The strategic importance of the project goes beyond the Moroccan domestic market.

Aishelun intends to use its Tangier facility as a manufacturing and export base serving Europe, the Middle East and North Africa.

Tangier offers several advantages for this strategy: proximity to Europe, access to the Tanger Med logistics ecosystem, competitive industrial infrastructure, free-zone incentives and Morocco’s extensive network of international trade agreements.

For Chinese manufacturers, this combination is increasingly making Morocco an attractive location for establishing production capacity closer to major overseas customers.

Aishelun Continues Its International Expansion

Aishelun reported revenue of approximately RMB 989 million in 2025, representing year-on-year growth of 42.95%. Net profit attributable to the group reached approximately RMB 94.09 million, up 16.57%.

The company’s Moroccan investment therefore represents more than a standalone factory project. It is part of a broader internationalization strategy aimed at establishing overseas manufacturing capabilities and improving access to international markets.

SinoLink Insight

Aishelun’s investment illustrates an important evolution in Chinese investment in Morocco.

Chinese industrial projects are increasingly moving beyond simple overseas production. Investment agreements are incorporating measurable commitments related to local integration, employment, female participation, local procurement and investment milestones, while Moroccan authorities provide incentives tied to the effective delivery of these commitments.

For Chinese companies evaluating Morocco, understanding this framework early is essential. Selecting the right industrial zone, structuring the Moroccan entity, negotiating investment incentives, coordinating with the CRI and other authorities, and developing a realistic local integration strategy can significantly affect both the timeline and economics of an industrial project.

SinoLink Solutions supports Chinese companies throughout their investment journey in Morocco — from market entry and company establishment to industrial location, investment incentives, government coordination, construction support and ongoing operations.

From China to Morocco, we turn investment plans into successful operations.

 
 
 

Comments


bottom of page